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Abstract 
Osteoarthritis of the carpometacarpal joint at the base of the thumb (CMC1 OA) is 
common and causes difficulty in grasp, grip, and fine manipulation of the hand. Surgery 
is recommended after failure of non-operative treatment, and evidence from short and 
medium-term follow-up studies shows successful relief of pain and return of function. 
Previous investigations of epidemiology and risk factors were drawn from small case 
series or radiographic reviews; similarly, surgical outcomes studies have been limited 
by lack of robust follow-up. 
The objectives of this thesis were to: 1) evaluate the clinically important prevalence of 
CMC1 OA by age and sex using physician-assigned diagnoses; 2) study the impact of 
occupational load on the occurrence of CMC1 OA; and 3) evaluate surgical outcomes 
including register-based sick leave length as well as long-term follow-up in a tightly 
captured population. 
Epidemiologic analysis using the Skåne Healthcare Register showed a sex difference in 
prevalence of CMC1 OA with 2.2% of women compared to 0.6% of men assigned this 
diagnosis over a 15-year period, with peak prevalence in women at age 70-74 years. 
Occupational load analysis showed that jobs with the heaviest manual work stress 
conferred the greatest risk of a diagnosis of CMC1 OA, with a linear relationship 
between work load and thumb base OA in men. Lengthy sick leave periods were noted 
after both soft tissue and prosthetic implant arthroplasty (median 131 and 102 days 
respectively), but prosthetic implant surgery patients returned to work a mean of 30 days 
earlier than those treated with soft tissue arthroplasty. Finally, a single-site retrospective 
cohort study with 17 years mean follow-up of 96 of 100 (96%) patients after abductor 
pollicis longus (APL) tendon suspension interposition arthroplasty, showed good to 
excellent patient-rated pain and functional outcomes as well as grip and pinch 
comparable to the non-operated side. 
These findings confirm long-held beliefs that there is greater female prevalence of 
CMC1 OA and that heavy labor is associated with increased risk of CMC1 OA.  Surgical 
treatment can relieve pain and improve function, with prosthetic implant arthroplasty 
associated with earlier return to work. 
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Abbreviations 
APL Abductor pollicis longus 
AUSCAN Australian Canadian Osteoarthritis Hand Index 
CMC Carpometacarpal 
CMC1 Thumb carpometacarpal 
DASH Disabilities of the Arm, Shoulder and Hand 
QuickDASH  Quick-Disabilities of the Arm, Shoulder and Hand 
FCR flexor carpi radialis 
IC Intercarpal 
ICD-10 International Classification of Diseases, update 10 
IP Interphalangeal 
LRTI Ligament reconstruction and tendon interposition 
MCP Metacarpophalangeal 
OA Osteoarthritis 
PRWHE Patient-Rated Wrist and Hand Evaluation 
RC Radiocarpal 
SHR Skåne Healthcare Register 
SSIA Swedish Social Insurance Agency 
STT Scaphotrapeziotrapezoid 
ST Scaphotrapezoid 
VAS Visual Analog Scale 
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Introduction 
The thumb provides approximately 50% of the function of the hand, and is thought to 
be the most important digit for use of the hand.1 Thus, injury or disease impacting this 
joint are of concern. Osteoarthritis (OA) of the thumb base, or thumb carpometacarpal 
joint (CMC1) is common and has been observed more frequently in postmenopausal 
women.2 The typical complaints on presentation are pain, weakness, and decreased 
function in grasp and manipulation.3 
Pathophysiology 
The CMC1 joint is made up of the first metacarpal and the trapezium, which articulate 
at a unique joint composed of two interlocking saddles.4 The first metacarpal base has 
a radius of curvature that is 34% greater than that of the trapezial articulating surface,5 
allowing for the multiple motions of the thumb, including flexion, extension, abduction, 
adduction, and opposition.6 The bony anatomy of this complex joint allows the degree 
of motion which allows both fine manipulation and manual grasp. 
The stability of the CMC1 joint is based on the ligaments which provide constraint to 
motion and support during use. Bettinger et al described 16 ligaments in their study of 
the functional anatomy of the joint, and noted two key ligaments: the dorsoradial and 
the deep anterior oblique ligaments.7  Historical evidence focused on the anterior 
oblique or ‘beak ligament’ as the most important stabilizer of the CMC1 joint,8-10 but 
recent studies have supported the primacy of the dorsoradial ligament (DRL).11,12 
Anatomic studies have shown the dorsoradial ligament to be thick and stout, with a 
tripartite origin, conferring biomechanical advantage to prevent dorsal translation of the 
first metacarpal.13 
It is theorized that OA of the CMC1 joint occurs secondary to abnormal loading of the 
joint during functional use, due to insufficiency or laxity of the supporting ligaments.14 
This theory is supported by evidence of uneven contact loading in biomechanical 
analyses of arthritic joint15 as well as evidence of increased CMC1 OA in hyperlax 
individuals.16 The CMC1 joint has been shown to bear the highest load among the joints 
of the thumb, with biomechanical studies demonstrating that simple pinch placed loads 
of 12 kg across the CMC1 joint, compared to 3 and 5.4 kg at the interphalangeal and 
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metacarpophalangeal joints, respectively. Strong grasp causes loads approximately 10 
times higher in magnitude, up to 120 kg across the CMC1 joint.17 (Figure 1) 
Figure 1. Biomechanical modeling has shown differences in load borne by the interphalangeal (IP), metacarpophalangeal 
(MCP), and carpometacarpal (CMC) joints of the thumb.  (Figure created from data presented by Cooney and Chao, J 
Bone Joint Surg Am, 1977.) Used with permission. 
Diagnosis – Physical Examination 
Patients with CMC1 OA often present with prominence of the base of the first 
metacarpal, termed the ‘shoulder sign’, due to the adducted position of the metacarpal 
that develops as OA worsens.18 As the metacarpal adducts, the patient is forced to 
hyperextend the metacarpophalangeal (MCP) joint to get the thumb out of the palm, 
called a Z-deformity.2 
With CMC1 OA, palpation of the CMC1 joint is painful, as is the ‘grind test’ where 
axial load and shift of the metacarpal on the trapezium results in crepitance.19 Other tests 
include the extension test, where the metacarpal is passively extended out of the palm, 
and the adduction test, where the metacarpal is firmly pushed into the palm. These 
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maneuvers are positive in patients with CMC1 OA, and have been shown to have 94% 
sensitivity and 91% specificity compared to the CMC grind test.20 
Diagnosis – Imaging 
Plain radiographs are standard in the evaluation of CMC1 OA and include posterior-
anterior, oblique, and lateral views of the hand. Radiographs can show joint space 
narrowing, spurs, loose bodies, and the position of the metacarpal in relation to the 
trapezium.  Special views are used to focus on the CMC1 joint. These include the Robert 
view, which is an anterior-posterior view of the CMC1 joint and shows all four trapezial 
articulations.21 The Bett view is a true lateral of the CMC1 joint and shows the 
scaphotrapeziotrapezoid joint as well as the CMC1 joint.4 Finally, the CMC stress view 
evaluates the degree of dynamic laxity of the CMC1 joint as the patient has to actively 
press the MCP and interphalangeal (IP) joints together to place stress on the ligaments 
stabilizing the CMC1 joint.22 The amount of subluxation seen is divided by the width of 
the metacarpal base to produce the subluxation ratio (Figure 2). 
  
Figure 2.  The trapeziometacarpal stress ratio, defined as the ratio of radial subluxation (RS) divided by the articular width 
of the first metacarpal base (AW).  From Oren et al, J Hand Surg Am, 2009.  Reproduced with permission. 
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The role of advanced imaging in CMC1 OA is limited. While MRI evaluation has been 
described for evaluation of ligament integrity23 and early bony changes,24 the utility of 
MRI in clinical decision-making is not yet known. 
The radiographic severity of CMC1 OA is most commonly graded using the Eaton and 
Littler classification as described in 1973 (Table 1).25  This classification scheme, which 
focuses on joint subluxation as well as the size of the loose bodies or bone fragments 
about the joint, was later modified to include scaphotrapezial (ST) joint involvement.26  
Table 1.  Eaton-Littler Radiographic Classification for CMC1 OA 
Stage Description 
I Normal or slightly widened joint space (capsular distension due to synovitis); normal 
articular contours, and less than one-third joint subluxation on any radiographic view 
II At least one-third joint subluxation; small bone fragments < 2mm in diameter 
III Greater than one-third joint subluxation; bone fragments >2mm in diameter with slight joint 
space narrowing 
IV Advanced degenerative changes with cystic and sclerotic subchondral bone changes; 
trapezial osteophyte formation and involvement of the STT joint 
Adapted from Eaton RG, Litter JW, J Bone Joint Surg Am, 1973. Used with permission. 
An alternative classification used by many authors is the Kellgren-Lawrence grading 
scheme, described in 1957 and applicable to all joints. The authors graded OA severity 
based on osteophyte formation on the joint margins, periarticular ossicles, joint space 
narrowing, subchondral sclerosis, and pseudocysts (Figure 3).27 
Figure 3. Kellgren and Lawrence classification and delineation of osteoarthritis of the CMC1 joint. Ann Rheum Dis, 1957. 
Reproduced with permission. 
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While the Eaton-Littler classification is the most commonly used scheme,28 studies of 
interobserver agreement have shown only moderate agreement on radiological 
classification among hand surgeons and radiologists.29,30 Several recent cohort studies 
and randomized trials have preferentially used the Kellgren-Lawrence classification in 
grading CMC1 OA.31,32 The major difference between the two classifications is the 
Eaton score’s emphasis on the degree of radial subluxation, the significance of which 
has been debated. A recent study of 100 subjects showed that lower radial subluxation 
ratios were associated with higher Kellgren-Lawrence grades, but showed no correlation 
with Eaton-Littler scores.33 The authors theorized that joint stabilization by osteophyte 
formation and capsular stiffening decreased radial subluxation. 
Epidemiology 
Overall hand OA and specific CMC1 OA is common.3 Several epidemiological studies 
have shown that the hand is the second most common site affected by OA after the knee 
joint, with estimated rates of hand OA at 100 per 100,000 person-years, compared to 
240 per 100,000 person-years for the knee.34 
Many epidemiology studies are based on radiographic evidence of OA, as defined by 
Kellgren and Lawrence in their original article grading the severity of OA.27 Armstrong 
et al evaluated the prevalence of CMC1 OA in 143 post-menopausal women, and 
reported radiographic findings of OA in 25%, with 8% demonstrating both CMC1 and 
scaphotrapeziotrapezoid (STT) OA.3 Of these groups, one quarter of the women with 
isolated CMC1 OA were symptomatic. Sodha et al evaluated the radiographs of 615 
patients who presented with distal radius fractures for the presence and severity of 
CMC1 OA, and noted a sex difference in prevalence of OA. When stratified by severity 
of CMC1 OA and age>80 years, the prevalence was 66% in women compared to 23% 
in men.35 A Finnish register study similarly showed a radiographic difference in 
prevalence of CMC1 OA in men and women, in a sample of 3595 radiographs. The 
authors noted that women showed a 15% radiographic prevalence of CMC1 OA 
compared to men at 7%, with additional findings that BMI was directly correlated to 
CMC1 OA in both sexes.36 
It is well-known that radiographic signs of OA do not always translate to symptomatic 
OA, as shown by studies in the hip37 and CMC1 joints.38 The symptomatic prevalence 
of CMC1 OA in the Framingham Study was evaluated in 1,041 subjects between ages 
71-100 years.39 Women demonstrated a prevalence of 26.2% CMC1 OA, as measured 
by interviewer questionnaire and confirmed by radiographs, compared to men at 13.4%. 
Bijsterbosch et al evaluated a group of 308 patients with hand OA and stratified them 
into groups of isolated CMC1 OA, isolated interphalangeal (IP) joint OA, and combined 
symptoms.40 Using a standardized upper extremity functional score (the AUSCAN), the 
authors noted that symptomatic CMC1 OA patients had the highest (worst) scores for 
function compared to patients with IP joint OA, emphasizing the impact of symptomatic 
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OA being greater in the CMC1 joint. The majority of studies in the epidemiology of 
CMC1 OA have relied on either radiographs or census interviews for data.  
Risk Factors for Development of CMC1 OA 
Factors proposed to predispose to the development of CMC1 OA include age, 
genetics/family history, obesity and occupation. In a study of 59 patients noted to have 
incidental CMC1 OA on radiographs, older age was the only factor associated with 
more advanced radiographic CMC1 changes, after evaluation for body mass index, 
tobacco use, depression scale, and grip/pinch strength.41 Other studies have confirmed 
increased age as a risk factor for a diagnosis of hand OA.3,36,42  
In evaluating genetic risk, a study in Iceland evaluated patients seeking medical services 
for hand OA compared to non-symptomatic controls, and evaluated kinship coefficient 
(a measure of the probability of a genetic relationship between two individuals) and 
relative risk of hand OA diagnosis in family members. In a large cohort of 2,919 subjects 
with hand OA compared to controls, the kinship coefficient was significantly greater in 
the OA population for both the IP and CMC1 joints, and the relative risk of hand OA in 
sisters of female subjects was 2.0.43 A twin study in the UK also demonstrated an 
increase in risk of hand OA diagnoses, including CMC1 OA.44  These studies provide 
evidence of a familial risk for CMC1 OA. 
Obesity has been described as a risk factor for OA of multiple joints including the 
hand.45 In a large Finnish population study which included screening interviews and 
radiographs, increased body mass index was shown to be directly proportional to the 
prevalence of CMC1 OA in both men and women.36 
Finally, in considering occupation as a potential risk factor, increased risk of joint 
degeneration and OA due to impact of repetitive and heavier loading have been 
relatively consistently reported for the hip and knee,46,47 but the same evidence has not 
been shown for CMC1 OA. A few small studies have shown elevated odds ratios of 
hand OA in those engaged in work requiring dexterity or repetitive work, or with 
vibrational tools.48   
Conservative Treatment of CMC1 OA 
There are multiple non-operative treatments described to treat individuals with 
symptomatic CMC1 OA. Conservative management is generally recommended as 
initial treatment, as many patients’ pain and dysfunction are resolved by these 
modalities. 
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Medications 
While studies specific to the use of medications for the CMC1 joint are minimal, there 
is some evidence for short-term positive effects on pain with the use of oral and topical 
nonsteroidal anti-inflammatory drugs (NSAIDs).49  Comparative studies in patients with 
DIP joint OA have shown significant positive effects of NSAID topical gels or creams 
when compared to oral ibuprofen or acetaminophen.50 
Splinting 
The use of orthoses to both stabilize and rest the CMC1 joint is well-established, and 
has been shown to decrease symptom severity and improve function.51 There are 
multiple types of splints used, which can be divided by length – short or long opponens, 
which indicate either hand- or forearm-based splinting; and by material, generally 
thermoplastic or neoprene. A study comparing short vs. long opponens splints in 26 
hands showed similar improvement in CMC1 radiographic subluxation and pain in the 
short term; patients preferred the shorter splint.52 A recent randomized comparison of 
thermoplastic vs. neoprene splints in 62 patients showed no differences in Disabilities 
of the Arm, Shoulder, and Hand (DASH) scores, pain, grip or pinch; however, patients 
rated the neoprene splint as more comfortable.53 The results of a systematic review of 
12 studies on splinting for CMC1 OA showed no significant effect on pain or function 
in the short term, but moderate to large effects on pain and small to moderate impact on 
function in medium term follow-up, noting that evidence was of lower quality.54 
Splinting in combination with other modalities has also been shown to be effective. Day 
et al performed a prospective study of splinting in combination with a single 
corticosteroid injection into the CMC1 joint in 30 patients, noting relief of pain and 
improved DASH scores in those with milder Eaton stages of CMC1 OA, and minimal 
relief in those with more advanced OA.55   
Injections 
Corticosteroid is the most commonly studied standard injection for CMC1 OA.  
Glucocorticoids were isolated from the adrenal gland at the Mayo Clinic in 1929.56 As 
has been shown in other joints such as the knee and shoulder,57,58 intraarticular injection 
of steroid can decrease pain and improve function of the arthritic CMC1 joint, at least 
in the short term.59 A systematic review of the use of steroid injections at the CMC1 
joint showed positive benefits of pain relief for 1-3 months after injection.60 A 
randomized trial comparing steroid injection to placebo in 40 patients with moderate to 
severe CMC1 OA showed no differences in joint tenderness, pain, or patient global 
assessment at 4, 12, or 24 weeks after injection.61 
Hyaluronic acid injections are synthetic derivatives of hyaluronan, a component of joint 
synovial fluid,62 and have been used to treat knee OA.  Their use has been described at 
the CMC1 joint, with findings of pain relief and improvement of function sustained 
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longer in comparison to steroid.63 A randomized placebo-controlled trial comparing 
hyaluronate to corticosteroid and placebo in 60 patients showed early pain relief with 
steroid and placebo, and more sustained pain relief with hyaluronate.62 There were no 
significant differences in DASH scores, range of motion, or overall pain scores among 
the groups at any time point up to 6 months post injection. 
While other injection materials have been described, the literature on these is minimal. 
A randomized trial of platelet-rich plasma compared to steroid injection in 33 patients 
with Eaton grades I-III CMC1 OA showed significantly better pain scores, 
QuickDASH, and satisfaction at 1 year.64 A new innovation is the injection of 
autologous fat into the CMC1 joint.65 A prospective comparative study of fat injection 
vs steroid in 24 subjects showed sustained pain relief in the autologous fat group at 3 
months compared to the steroid group.66 
Therapy 
Therapeutic exercise for CMC1 OA can be beneficial to increase strength and joint 
mobility.  Specific modalities such as first dorsal interosseous muscle activation, 
thought to ‘reduce’ the subluxated CMC1 joint and thus pain and dysfunction, have 
been described.67 Wouters et al performed a prospective cohort study with propensity 
score matching to compare therapeutic exercise and orthotics to orthotics alone in 84 
patients, and noted a larger decrease in pain visual analog scale (VAS) at rest and with 
loading in the exercise/orthotics group compared to the orthotic only group.68 
Surgical Options and Outcomes 
There are multiple surgical options for CMC1 OA, and these can be stratified practically 
by early-stage and late-stage of OA. 
Surgery in Early-Stage CMC1 OA 
In the patient who presents with pain at the CMC1 joint but no or minimal signs of OA 
on radiographs, and has failed conservative management, options for treatment include 
ligament stabilization as described by Eaton and Littler; dorsoradial capsular 
imbrication; CMC1 joint arthroscopy and synovectomy; or metacarpal extension 
osteotomy. 
Ligament stabilization of the CMC1 joint was described for the hypermobile patient, 
and involves restoring the stability of the CMC1 joint by transfer of one-half the flexor 
carpi radialis (FCR) tendon through a transverse drill hole in the base of the first 
metacarpal, thus restoring dorsal and volar stability.25 A retrospective study of 35 
patients treated with this procedure and followed up at an average of 5.2 years showed 
67% excellent and 30% good results, with nearly all reporting complete pain relief.69 
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The concept of reinforcing or imbricating the dorsoradial ligament in a lax CMC1 joint 
makes sense as this is now considered the key ligament for stability.  Rayan and Do 
described the technique and case series in 5 patients, noting good relief of pain and 
improved function.70 Other small series have noted similar good outcomes.71 
CMC1 joint arthroscopy was originally described by Menon, who performed 
synovectomy and interposition with autogenous tendon, allograft, or synthetic material 
in 33 patients.72 Yao and others have described both interposition and 
hemitrapeziectomy as arthroscopic techniques,73 with a recent study suggesting that 
arthroscopic resection arthroplasty alone is just as efficacious in relieving pain and 
improving function when compared to arthroscopic resection and interposition.74 
Finally, metacarpal extension osteotomy was described as a way to redistribute the 
forces through the CMC1 joint by shifting the load area to relieve pain.75  A 
retrospective study of 12 patients with a mean followup of 2.1 years treated with 
osteotomy reported increased grip and pinch, with high satisfaction.76 
Surgery in Late-Stage CMC1 OA 
When conservative treatment of CMC1 OA fails, the classically described surgical 
treatment is removal of the trapezium77 with additional procedures to further stabilize 
the first metacarpal base such as tendon suspension;78-80 or implant arthroplasty to 
replace the joint using silicone or metal materials.81-84 
Simple removal of the trapezium was first described in a case report in 1947 as a way 
to treat CMC1 OA.77 Davis et al demonstrated in a randomized prospective study that 
the 1-year outcomes of simple trapeziectomy were comparable to those after tendon 
interposition or ligament reconstruction in 76 women with CMC1 OA.85 Long-term 
follow-up has confirmed these results.86,87 
While the need to suspend the first metacarpal or reconstruct the ligaments has been 
debated, there are multiple techniques described to perform this.  Burton and Pellegrini 
described the well-known ligament reconstruction and tendon interposition (LRTI), in 
which half the FCR tendon was harvested and placed through a drill hole in the first 
metacarpal base to both reconstruct the ligaments and act as a spacer within the trapezial 
gap.78   
The use of the abductor pollicis longus (APL) tendon has been described as an 
alternative option for suspension of the first metacarpal, with the advantages of surgery 
through a single incision.88 Other techniques include the Weilby suspensionplasty, 
whereby the FCR tendon is harvested and looped in a figure-of-eight fashion around the 
APL to provide a sling.89 Other ways to suspend the first metacarpal include suture 
suspension90 and the use of commercial suture-button modalities.91 While there are 
several reports of short term results after FCR and APL suspension,92,93 there is a paucity 
of studies focused on long-term outcomes after trapeziectomy and suspensionplasty.94,95  
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Alternatives to trapeziectomy and suspensionplasty include arthrodesis or implant 
arthroplasty. Arthrodesis has traditionally been limited to younger laborers,96 but some 
authors have expanded their indications to patients of middle age and reported function 
and pain relief similar to LRTI in comparative series.97 A randomized trial comparing 
trapeziectomy/LRTI to arthrodesis in 43 women was terminated due to a high rate of 
complications in the arthrodesis group, specifically hardware issues and non-union, 
although outcomes measured by DASH and Patient-Rated Wrist and Hand Evaluation 
(PRWHE) scores were similar.98 
Implant arthroplasty for the CMC1 joint was originally described by Swanson, who 
proposed and created a silicone rubber implant with intramedullary fixation into the 
base of the first metacarpal after trapezial removal.99 Long-term outcomes of silicone 
arthroplasty have shown mixed results, with concerns for silicone synovitis and 
failure100 but other reports showing low revision rates and high patient satisfaction.81 
Alternative implant materials include metal/plastic101 and pyrocarbon,102 with medium-
term outcomes showing mixed results.103 While high patient satisfaction and good pain 
relief are reported, more comprehensive studies including register data have shown 
survivorship between 70-90% at 5-10 years with complications including implant 
dislocation, fracture, and need for revision.104-106 
With multiple surgical techniques described for CMC1 OA, the literature includes many 
series and cohort studies showing successful relief of pain and good function in the short 
term.107,108 Comparative studies have shown that soft-tissue arthroplasty is overall 
successful, with simple trapeziectomy showing the lowest rate of complications.109 
Implant arthroplasty has higher failure and revision rates when compared to soft tissue 
surgery.110,111 
Sick Leave after CMC1 Surgery 
There are very limited data specifically addressing sick leave after CMC1 surgery.  A 
number of single-center studies have noted return to work as a factor reported in the 
outcomes of surgery.  A study of trapeziectomy and LRTI reported that 25 of 28 (89%) 
patients were able to return to their previous occupation, but did not stratify patients by 
occupation or time to return to work.112  A prospective study of 20 patients with a mean 
age of 55 years (range, 43-65 years) treated with arthroscopic partial trapeziectomy 
reported return to work for 7/16 (44%) employed patients at 3 months. By 6 months, 
14/16 (88%) had returned to their occupation.113 Another study compared 34 
trapeziectomies combined with tendon interposition to 35 trapeziectomy-
suspensionplasty cases, and noted nearly equivalent strength and satisfaction, but poor 
endurance at work in both groups. Although there was no specific work-level data, the 
authors stated that it took 2 years for patients to return to normal activity post-surgery.114 
Studies of post-surgery sick leave in the Swedish population have shown variable time 
out of work based on the type of surgery performed.  A study of carpal tunnel syndrome 
showed median duration of sick leave after surgery was 35 days in women and 41 days 
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in men.115 In evaluation of knee and hip replacement surgery, more analogous to CMC1 
surgery, Stigmar et al showed a median sick leave length of 117 days in women and 96 
days in men following surgery.116 
Revision after CMC1 Surgery 
The need for revision after CMC1 surgery is low, based on the evidence. A single-center 
retrospective analysis of 654 procedures at the Mayo clinic showed that 15 patients with 
17 arthroplasties (2.6%) required revision.117  These were all soft-tissue arthroplasties, 
and revision surgery included neurolysis, soft-tissue interposition, or ligament 
reconstruction, with good results reported in 13/17 and failures of revision in 4, 
associated with nerve injury. Megerle et al reported on 12 patients undergoing 
secondary surgery, with an overall revision rate of 2.9% at a single center, with the most 
common reasons for revision being residual osteophytes at the base of the first 
metacarpal, superficial radial neuroma or injury, and scaphotrapezoid OA.118 
A retrospective database review at two institutions noted 32 patients undergoing 
revision CMC1 surgery at a mean age of 58 years, with median time to revision of 34 
months (range, 6-133 months).119 All patients had pain and radiographic metacarpal 
subsidence, with 11/32 with ST joint OA. This group was treated with distraction 
pinning, combined with multiple soft tissue procedures. 
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Aims 
I. To evaluate the clinically important prevalence of CMC1 OA by age and 
sex using physician-assigned diagnoses   
II. To examine the impact of varying load by occupation on the odds of a 
diagnosis of CMC1 OA in the working population, and to analyze 
differences in risk of CMC1 OA by sex 
III. To evaluate sick leave after surgery for CMC1 OA, with specific 
comparison of soft tissue versus implant arthroplasty surgery in a large 
population of working age 
IV. To assess long-term outcomes after APL tendon suspension-interposition 
arthroplasty surgery with physical examination, patient reported outcomes, 
and radiographs 
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Subjects and Methods 
Region Skåne 
This research study is based on data derived from the population of the Skåne region in 
Sweden, in the southernmost portion of the country (Figure 4). 
 
Figure 4. Map showing location of Skåne (highlighted) in southern Sweden. 
This geographic region encompasses 33 municipalities and has a total population of 
1.32 million residents (2016 data, Statistics Sweden), making up 13% of the Swedish 
population overall.  The population density is high, at 121 persons per square kilometer, 
compared to the average population density in Sweden at 25 persons/km2.120 
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Register Data and Research 
Because of the location of Lund University in Skåne as well as government support of 
register and epidemiological studies, there is a multitude of epidemiological cohorts 
existing in Skåne. Some examples include the Malmö Offspring Study, formed in 2013 
with the goal to map family patterns of cardiovascular disease and diabetes,121 and the 
Malmö Diet and Cancer Study (MKC) with original enrollment of 17,000 women and 
11,000 men, focused on the link between diet and cancer.122   
Three of the studies presented in this thesis involve the use of data derived from several 
registers, some internal to Skåne and some at the national level.   In evaluation of 
epidemiology, occupational risk, and sick leave, we accessed data from the Skåne 
Healthcare Register (SHR). The SHR is an administrative healthcare repository, with 
information from medical records and administrative data collected from healthcare 
accessed in Region Skåne from 1998-present.123 It includes individual-level data in both 
primary and specialty care, on an in-patient and outpatient level, and captures each 
contact with healthcare. The SHR also captures the diagnostic codes as assigned by 
physicians using International Classification of Diseases-10 (ICD-10). Studies of 
coding accuracy in the SHR have shown high validity in assigned diagnoses.123 
For information on occupation and sick leave, we accessed the Swedish Social 
Insurance Agency register.124 This database contains annual data collected since 1990 
on all individuals aged 16 years or older, including individual-level information on 
registered occupation, places of employment, disability and other compensation, highest 
level of education, and residence. Because data are identified by personal identification 
number, this information can be crosslinked with SHR data for correlation with health 
records. 
The Skåne population register and Swedish cause of death register were utilized to 
confirm individuals who had moved out of the region or had died.125 The population 
register contains linked data by identification number, with information on residency, 
family, marriage status, and civil registration. The electronic version of the death 
register has been in existence since 1952, with multiple data points including ICD-10 
codes. 
Ethical Approval 
Papers I, II, and III all used data derived from register information. The use of the SHR 
data was approved by the regional ethics board as an opt-out study, in that data is 
included automatically unless a resident of Skåne contacts a study’s principal 
investigator to restrict access to their health data. All data is retrieved using the 
encrypted personal identification number that is unique to every individual Swedish 
29 
citizen, with no access to identifying characteristics such as name or address. Use of 
linked data from the SSIA database was approved by ethical screening with 
confirmation that data was anonymised. 
The protocol for the study in Paper IV was approved by the Regional Ethical Review 
Board (# 2018-485) and each patient included gave written informed consent for 
participation. 
Definition of Doctor-Diagnosed CMC1 OA (Paper I) 
Previous prevalence studies defined CMC1 OA based on radiographic criteria,35,42,126 or 
self-defined diagnosis, i.e. an affirmative answer to a study interviewer who asks “do you 
have arthritis in your hand?”127,128 Other studies have performed detailed interviews by 
trained nurses, with followup radiographs.36 We believe a physician-assigned diagnosis is 
the most stringent method of diagnosis of CMC1 OA, in that the physician is evaluating 
a patient who specifically sought care for this issue and can use comprehensive criteria, 
to include history, physical examination, and imaging, to make this diagnosis.129,130   
The SHR data includes diagnostic codes derived from the ICD-10. The ICD-10 codes 
were introduced in 1992 by the World Health Organization as an update to the previous 
revision, and included many more codes for specificity of location and disease, 
including joint-specific codes.131  These codes are input by physicians for each clinical 
encounter. We queried the SHR for physician-diagnosed CMC1 OA using the ICD-10 
code specific to CMC1 OA, which is M18 (including subsets M18.0, M18.1, M18.2, 
M18.3, M18.4, M18.5 and M18.9, some of which characterize post-traumatic or 
secondary OA at this joint). 
In this study, we included all residents of Skåne from age 20 years, who had an M18 
code assigned from 1998-2012. We excluded those who had died or moved outside the 
region using linkage with the population register. One code per patient was counted; 
because approximately 30% of all outpatient care in Skåne is provided by private 
practice, with diagnostic codes not routinely included in the register, we reduced the 
population denominator by 20% to account for this loss of codes. We chose to reduce 
the denominator by less than 30% because register data has shown that approximately 
one-third of patients who are managed in private health care for a specific condition also 
are seen at some point in the course of their condition by a provider in the public system, 
where the coding is captured.132 
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Stratification of Occupational Load (Paper II) 
In order to evaluate for a relationship between occupational load and a diagnosis of 
CMC1 OA, it was necessary to categorize the amount of load stress by occupation. The 
Swedish Occupational Register contains information on the occupation of all persons 
aged 16 years or older, reported yearly by employers. The register classifies individuals 
into categories using the Swedish Standard Classification of Occupations (SSYK) from 
2012, which is based on the International Standard Classification of Occupations-08 
(published in 2008). This classification is an international standard adopted by the 
International Labour Office with support from the United Nations.133  The ISCO (and 
thus the SSYK) divide occupations into 10 major groups. (Table 2) 
Table 2. Categories from the International Standard Classification of Occupations 
ISCO Major Group Number ISCO Definition 
1 Managers 
2 Professionals 
3 Technicians and Associate Professionals 
4 Clerical Support Workers 
5 Services and Sales Workers 
6 Skilled Agricultural, Forestry, and Fishery Workers 
7 Craft and Related Trades Workers 
8 Plant and Machine Operators and Assemblers 
9 Elementary Occupations 
0 Armed Forces Occupations 
Each of the major groups has a number of subset types into which the ISCO-08 and 
SSYK place individuals. In order to define occupational load, we stratified occupations 
by load into light, light-moderate, moderate and heavy occupational load based on a 
previous occupational study.134 We also separately defined a subset of occupations 
requiring repetitive hand use, which included restaurant staff, nurses, dental hygienists, 
and computer workers.  These occupations drew from every occupational level except 
heavy or manual labor. 
Using this classification scheme, we identified all individuals between 30-65 years of 
age who received at least two diagnoses of CMC1 OA between 1998-2013. We then 
created a control cohort by matching up to 4 individuals by birth year, sex, postcode and 
level of education. To estimate the relationship between load and occupation, we linked 
the case and control cohorts to occupation using the occupational register. We defined 
exposure by assigning each person in both groups to the profession in which they were 
registered in 2013. 
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Measurement of Sick Leave Time (Paper III) 
In order to measure sick leave taken in relation to a surgical procedure for CMC1 OA, 
we cross-referenced data from the SHR with individual level data from the Swedish 
Social Insurance Agency. In Sweden, the first 14 days of leave for illness are paid by 
the employer, and thus this payment cannot be differentiated from salary pay. Those 
persons with disability pension documented in the 365-day period before the identified 
surgery date occurred were excluded. 
We identified two surgical cohorts of individuals undergoing surgery for CMC1 OA by 
querying the SHR for the following: 
1. Code of M18 to indicate CMC1 OA 
2. Procedure code of NGD12 (soft tissue CMC-I arthroplasty) or NDB (prosthetic 
implant arthroplasty) 
3. Age between 40-59 years 
4. Resident of Region Skåne a full year prior to date of surgical procedure code 
 
Using the SHR, two surgical cohorts were analyzed:  421 people who were treated with 
soft tissue arthroplasty and 220 people who underwent prosthetic implant arthroplasty 
during the 8 year period from 2004-2012.  Reference cohorts totalled 1,677 persons for 
the soft tissue arthroplasty group and 874 persons for the prosthetic implant group. 
We then excluded 95 and 567 persons in the soft tissue group and reference group 
respectively due to sick leave in the year before the surgical date. Similarly, 51 and 300 
persons were excluded in the prosthetic implant cohort for the same reasons. 
We also created a comparison control group by matching 4 individuals to each case 
individual by birth year and sex, each of whom had consulted for any medical care noted 
within the SHR. These control subjects were excluded if they had disability pension in 
the year before the index date of surgery of their case matched subject. 
Long Term Followup of a Surgical Cohort (Paper IV) 
From the orthopedic surgery register for Skåne, we identified all adults who had been 
treated with surgery at one orthopedic department (Hässleholm and Kristianstad 
Hospitals) for the diagnosis code for CMC1 OA (ICD-10 code M18.0 or M18.1) over 
the time period 1998-2005. We then limited the cohort to patients who were treated with 
surgical trapeziectomy and APL suspension-interposition arthroplasty. Each patient was 
then contacted by a research nurse and asked to attend the hospital for clinical and 
radiographic evaluation. 
We evaluated each patient for range of motion of the thumb CMC, MCP, and IP joints, 
as well as wrist flexion, extension, radial deviation and ulnar deviation. We also 
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measured grip strength and key pinch strength. Each patient had radiographs of both 
hands, with three standard views obtained. 
Each patient completed the following standardized outcomes questionnaires:  
QuickDASH,135 a thumb-specific 2-item pain scale to rate the severity of pain in the 
thumb and related activity limitations,136 VAS to measure pain,137 and were asked to 
rate their satisfaction with the results of surgery (satisfied, somewhat satisfied or 
dissatisfied).  
Data from the National Quality Registry for Hand Surgery (HAKIR) 
Because preoperative patient-reported outcome measures were not available, we 
obtained data from two referent cohorts from the Swedish national quality registry for 
hand surgery (HAKIR).138 Specialized hand surgery departments in Sweden register all 
surgeries in HAKIR by ICD-10 codes and Scandinavian surgical codes. Patient-reported 
outcome is collected preoperatively and 1 year postoperatively, including the 
QuickDASH and three questions about pain: pain on load, pain on motion without load, 
and pain at rest, scored on a scale with 10-point increments 0 to 100 (lower is 
better).139,140  
In the present study we used preoperative registry data (pain and QuickDASH) for all 
patients, within the same age span as the study cohort, who between April 2011 and 
January 2020 were treated for CMC1 OA with trapeziectomy and any type of tendon 
suspension-interposition arthroplasty (because the indication for surgery is usually 
similar irrespective of the type of tendon used). We also obtained 1-year postoperative 
registry data for patients treated specifically with trapeziectomy and APL suspension-
interposition arthroplasty. 
Epidemiological Methods 
Prevalence 
We calculated the overall prevalence for the diagnosis of CMC1 OA from 1998-2012, 
then stratified by gender and age. We also evaluated the incidence within the year 2012, 
as an incidence proportion using the known Skåne population for that year, and 
compared this to the prevalence over time. We also performed a sensitivity analysis to 
confirm robustness of the data. This was done to examine variables with expected 
impact on the analysis - in this case, life expectancy and the chance in that time period 
that someone would be diagnosed with this disease. The analysis was performed by 
multiplying the 2012 incidence with the mean disease duration. This was defined as 
equal to the remaining number of years of life expectancy at age 65, derived from 
Statistics Sweden.   
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Conditional Logistic Regression Analysis 
In evaluation of occupational exposure, we analysed for a relationship between load and 
CMC1 OA diagnosis using conditional logistic regression. We used a conditional model 
because of the matched population, with 4 controls matched by sex, birth year, postcode 
and education level. Using this analysis, we derived odds ratios for associations between 
the selected group and a CMC1 OA diagnosis. 
Negative Binomial Regression 
Negative binomial regression is used to compare counts (or the number of times an 
event occurs). We used this technique to compare sick leave between surgical cohorts, 
after calculating the mean number of sick leave days for each month for 12 months 
before and 24 months after surgery. The differences in sick leave days were expressed 
using incidence rate ratios, with 95% confidence intervals.   
This model was chosen because days of sick leave are count variables with variance of 
the means that exceed the mean. Negative binomial regression is typically used for over-
dispersed count data such as this. 
Linear Mixed Effects Regression Model 
To evaluate the association between trapezial space on radiographs and pinch strength 
at the thumb, we used a linear mixed effects regression, with the exposure being the 
trapezial space and the outcome as pinch strength.  The model was adjusted for 
confounders including pain, age, sex, and grade of OA.   
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Results 
Prevalence of CMC1 Osteoarthritis (Paper I) 
Using the population of region Skåne in 2012, reduced by 20%, we defined the 
population denominator as 780,204 persons. We identified the total number of residents 
given a CMC1 OA diagnosis as 11,111. The overall prevalence for the diagnosis was 
1.42% (95% CI, 1.40 to 1.45). Stratified by gender, the prevalence of CMC1 OA was 
2.2% in women vs. 0.6% in men. The highest prevalence in women was at age 65-70 
years (5.1%) and in men at 75-80 years and greater than 80 years, both 1.9%. (Figure 5) 
 
Figure 5.  Prevalence of CMC1 OA by age and sex. 
The incidence in the year 2012 was 228 per 100,000 in women and 71 per 100,000 in 
men. The sensitivity analysis showed that an expected point prevalence would be 4.8% 
in women and 1.3% in men, which are similar to the actual results for the prevalence in 
that age group.  
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Positive Relationship between Occupational Load and 
CMC1 OA (Paper II) 
Using the SHR, we identified 3,813 people with a diagnosis of CMC1 OA in region 
Skåne in 2013.  We then excluded those serving in the military (32 persons), 41 persons 
with missing data, and those not assigned to any occupation in 2013. The overall study 
sample included 3,462 CMC1 OA patients and 13,211 controls. 
The CMC1 population had a mean age of 63 years, consisting of 2770 women and 692 
men (Table 3). 
Table 3. Occupational Exposure for Men and Women CMC1 OA Cases and Controls 
n (%) Age (years), mean (SD) 
Level of work demand CMC1 OA cases Controls CMC1 OA cases Controls 
Men, all categories 662 2532 63 (7) 63 (7) 
Light 194 (29) 997 (39) 64 (7) 63 (7) 
Light-moderate 71 (11) 302 (12) 62 (9) 63 (8) 
Moderate 79 (12) 268 (11) 63 (8) 63 (8) 
Heavy 318 (48) 965 (38) 62 (8) 63 (8)      
Women, all categories 2838 10,679 63 (7) 63 (7) 
Light 1209 (43) 5311 (50) 64 (7) 64 (7) 
Light-moderate 1106 (39) 3499 (32) 63 (7) 63 (7) 
Moderate 363 (13) 1308 (12) 63 (8) 63 (8) 
Heavy 160 (6) 561 (5) 62 (8) 63 (8) 
We found that the heavy occupational load group had a significantly higher odds of 
having a CMC1 OA diagnosis overall, with a dose-response effect in men. The overall 
estimated ORs for CMC1 OA were 1.46 (95% CI, 1.33 to 1.60) for light-moderate 
manual work, 1.34 (95% CI, 1.18 to 1.53) for moderate manual work, and 1.58 (95% 
CI, 1.38 to 1.82) for heavy manual work as compared with the light work category as 
the referent. When stratified by sex, the analysis showed a dose-response pattern in men, 
with heavier occupational demand associated with higher OR for doctor-diagnosed 
CMC1 OA (Table 4). We did not find a similar association for women, although all 
three occupational categories were associated with higher odds of CMC1 OA compared 
to the referent light work population.  
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Table 4. Occupational Level and Odds Ratio (OR) for CMC1 OA Diagnosis  
 All Men Women 
 OR 95% CI OR 95% CI OR 95% CI 
Light  referent referent referent referent referent referent 
Light-moderate  1.46 1.33 to 1.60 1.31 0.96 to 1.79 1.46 1.32 to 1.61 
Moderate  1.34 1.18 to 1.53 1.76 1.29 to 2.40 1.27 1.10 to 1.46 
Heavy  1.58 1.38 to 1.82 2.00 1.59 to 2.51 1.31 1.07 to 1.59 
 
We performed a second analysis to compare occupations defined as repetitive to both 
light and heavy loads and noted that repetitive occupations had a higher risk of CMC1 
diagnosis (overall 1.31, 95% CI 1.18 to 1.46) than the light referent group, but still less 
than the heavy group (1.75, 95% CI 1.48 to 2.06), and that women in repetitive 
occupations had risks of CMC1 diagnosis comparable to those in heavy occupations 
(Table 5). 
Table 5.  Repetitive Occupations and Odds Ratio (OR) for CMC1 OA Diagnosis 
 All Men Women 
 OR 95% CI OR 95% CI OR 95% CI 
Light  (n=4752) referent referent referent referent referent referent 
Repetitive (n=2393) 1.31 1.18 to 1.46 1.47 1.08 to 2.01 1.27 1.14 to 1.43 
Heavy (n=1861) 1.75 1.48 to 2.06 2.30 1.76 to 3.02 1.41 1.12 to 1.77 
 
Sick Leave is Shorter after Prosthetic Implant Arthroplasty 
Surgery Compared to Soft Tissue Arthroplasty Surgery 
(Paper III) 
After exclusions, we compared 169 individuals who underwent prosthetic arthroplasty 
to 326 who were treated with soft tissue surgery. Table 6 shows the remaining surgical 
and control subjects available for analysis: 
Table 6. Surgical and Control Cohorts by Sex and Age 
 Surgical Cohort, n 
Reference Cohort, n 
Women, n (%) Men, n (%) Mean Age, y (SD) 
Soft tissue 
arthroplasty 
326 
1,1110 
286 (88) 
970 (87) 
40 (12) 
140 (13) 
54 (4) 
54 (4) 
Implant arthroplasty 169 
574 
138 (82) 
466 (81) 
31 (18) 
108 (19) 
55 (4) 
54 (4) 
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In the soft tissue arthroplasty group, 261 of 326 (80%) had documented sick leave after 
surgery. The duration in women was a mean of 202 days (median, 124 days). In men, 
the mean sick leave was 170 days (median, 138 days) (Table 7). We then excluded the 
data of those individuals who had sick leave for any reason 8 to 30 days prior to surgery 
– using this factor as a proxy for a 'healthier' group without other illnesses or reasons to
be out of work. This group was composed of 152 women and 23 men.  In this group,
the mean and median duration of sick leave in women were 137 and 100 days after soft
tissue arthroplasty, respectively; men were out of work a mean of 125 days and a median
of 90 days post surgery.
Table 7. Sick Leave by Procedure Type 
Procedure Number of 
Subjects 
Number 
with Sick 
Leave Days 
(n) 
Mean (SD) 
Days of Sick 
Leave 
Median 
Days of 
Sick 
Leave 
10th 
percentile 
(days) 
90th 
percentile 
(days) 
Soft Tissue Arthroplasty 
All Surgical 
Patients 
326 261 
Women 286 228 202 (192) 124 55 539 
Men 40 33 170 (144) 138 77 371 
Subgroup with No 
Sick Leave before 
Surgery* 
240 175 
Women 210 152 137 (127) 100 50 226 
Men 30 23 125 (93) 90 53 192 
Implant Arthroplasty 
All Surgical 
Patients 
169 146 
Women 138 121 177 (190) 95 56 445 
Men 31 25 188 (236) 71 29 720 
Subgroup with No 
Sick Leave before 
Surgery* 
117 94 
Women 93 76 109 (117) 79 43 148 
Men 24 18 94 (127) 62 29 153 
*Patients with no registered sick leave 8-30 days before the surgery date. 
In the implant arthroplasty group, 146 of 169 (86%) had documented sick leave time 
after surgery.  In the overall group, the mean duration of sick leave was 177 days for 
women (median, 95 days) and 188 days for men (median, 71 days).  We performed a 
similar exclusion as was done in the arthroplasty group to examine a more healthy 
cohort with no sick leave in the month prior to surgery. This group, composed of 94/169 
patients (55%), was made up of 76 women and 18 men.  Women had a mean of 109 
days sick leave (median, 79 days) and men had 94 days of sick leave (median, 62 days).   
Overall, sick leave was lower in all categories when comparing the prosthetic to the soft 
tissue arthroplasty groups, although the differences were not significant (IRR 0.91, 95% 
CI 0.77 to 1.08). When comparing the groups with no sick leave 8-30 days prior to 
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surgery, the differences between surgical types were significant with prosthetic implant 
patients having a shorter time out of work (IRR 0.79, 95% CI 0.66 to 0.94). 
Comparing sex and age, we noted no differences. Women had IRR of 1.07 compared to 
men with regard to sick leave (95% CI 0.85 to 1.35). Age also did not affect sick leave 
length (IRR 0.99, 95% CI 0.97 to 1.01). 
Trapeziectomy and APL Suspension-Interposition 
Arthroplasty Surgery is Durable and Effective in Long-
Term Followup (Paper IV) 
The original cohort of 100 patients (125 hands) was composed of 92 women and 8 men 
with a mean (SD) age of 59 (6) years at the time of surgery. Surgical side was nearly 
evenly divided between right and left; 99 patients were right hand dominant. Mean 
followup time was 17 (range, 13-21) years. (Table 8) 
Table 8. Patient Characteristics 
 All Women Men 
No. of Patients (Hands) 100 (125) 92 (117) 8 (8) 
Side (n) 
     Right 
     Left 
 
62 
63 
 
59 
58 
 
3 
5 
Age at surgery, median (range) y* 58 (42-72) 58 (42-72) 57 (42-71) 
Age at follow-up, median (range) y* 74 (61-90) 74 (61-90) 74 (62-86) 
Follow-up length, mean (range) y* 17 (13-21) 17 (13-21) 17 (13-20) 
*Data for the 96 patients (119 hands) who participated in follow-up. 
Of the group of 100 patients (125 hands) that underwent trapeziectomy and APL 
suspension-interposition arthroplasty, 80 subjects (101 hands) were available for 
follow-up examination in 2018. A total of 71 women and 7 men with a mean age (SD) 
of 74 (6) years were examined by one of two hand therapists.  
For the operated study hands of all respondents to the thumb pain scale (n=119), the 
mean thumb pain score was 19 (SD 26, median 0), with a score of 0 (no pain and related 
activity limitations) recorded in 71 (60%) of the study hands and score below 30 in 17 
(14%) of the hands. In patients with unilateral surgery the mean and median thumb pain 
scores were lower in the study hands than in the contralateral hands (Table 9). For the 
operated study hands of all respondents to the full questionnaire (n=108) the hand pain 
VAS score was 20 (SD 25, median 20) and QuickDASH score 25 (SD 22, median 21). 
In patients with unilateral surgery the mean and median hand pain VAS and 
QuickDASH scores did not differ between the study and contralateral hands, with mean 
QuickDASH of 27 in the operated and 28 in the contralateral hand.  
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Table 9. Patient-Reported Outcomes Measures 
Scale Unilateral Surgery 
n=64* 
Bilateral Surgery 
n=22† 
Operated Contralateral Right Left 
mean 
(SD) 
median 
(quartiles) 
mean 
(SD) 
median 
(quartiles) 
mean 
(SD) 
median 
(quartiles) 
mean 
(SD) 
median 
(quartiles) 
Thumb Pain scale‡ 20 (28) 0 (0, 48) 29 (31) 16 (0, 59) 16 (24) 0 (0, 28) 16 (25) 0 (0, 49) 
Hand Pain VAS 24 (26) 20 (1, 36) 29 (27) 21 (5, 50) 30 (28) 30 (2, 50) 16 (19) 7 (1, 31) 
QuickDASH 27 (21) 25 (8, 40) 28 (22) 24 (8, 39) 25 (25) 18 (6, 48) 21 (20) 15 (5, 42) 
Score range: 0 (best) to 100 (worst) 
*16 patients had undergone contralateral APL arthroplasty (6 before and 10 after the study period) and 2 patients had 
undergone contralateral CMC1 fusion before the study period; 5 patients with only questionnaire response (2 had 
undergone contralateral CMC1 fusion during the study period before the surgery on the study hand). 
†1 patient with only questionnaire response. 
‡Completed (through telephone interview) by additional 9 patients with unilateral surgery (2 had contralateral CMC I fusion 
prior to the tendon arthroplasty) and 1 patient with bilateral surgery. 
The pain and QuickDASH scores were generally similar to the 1-year postoperative 
scores in the hand surgery registry cohort (Table 10). The difference between the mean 
preoperative and postoperative QuickDASH scores is greater by a large margin than the 
minimal clinically important difference (MCID)141 of 6.8 for the QuickDASH. 
Table 10. Referent Cohorts from the Swedish Quality Registry for Hand Surgery (HAKIR) and the Study Cohort 
 HAKIR Register Referent Cohorts Study Cohort 
 Preoperative* 1y Postoperative 13-21y Postoperative 
 Women 
n=656 
Men 
n=146 
Women 
n=44 
Men 
n=15 
Women 
n=101 
Men 
n=7 
Age at surgery (y) 59 (7) 62 (5) 59 (8) 65 (7) 58 (6) 62 (8) 
Side, n (%)       
     Right 323 (49) 59 (40) 25 (67) 6 49 (49) 3 
     Left 333 (51) 87 (60) 19 (43) 9 52 (51) 4 
Pain at rest 52 (25) 45 (26) 14 (23) 3 (5)   
Pain on motion without 
load 
60 (21) 51 (23) 19 (23) 6 (13)   
Pain on load 77 (16) 73 (19) 31 (29) 14 (20) 19 (26)‡ 17 (29)‡ 
QuickDASH 57 (16) 48 (16) 29 (24) 12 (12) 26 (22) 17 (15) 
Values are mean (SD). Score range 0 (best) to 100 (worst). 
*Patients who had underwent trapeziectomy and any type of tendon interposition arthroplasty, including APL in 92 women 
and 26 men. 
†Patients who underwent trapeziectomy and APL suspension interposition arthroplasty. 
‡Thumb-specific 2-item pain scale score range from 0 (best) to 100 (worst) 
Patients stated that they were very satisfied with the outcome in 87 hands (86%) whereas 
in 14% they stated being either rather satisfied (13 hands) or dissatisfied (1 hand).  
Additionally, range of motion measurements of the thumb and wrist were similar to the 
contralateral hand. (Table 11) 
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Table 11. Physical Examination Measures 
 Unilateral Surgery 
n=59* 
Bilateral Surgery 
n=21 
 Operated Contralateral Right Left 
Strength (kg) (SD)     
 Grip 17.1 (7.0) 17.2 (7.4) 16.3 (7.4) 15.7 (6.8) 
 Tip Pinch 4.3 (1.4) 4.8 (1.6) 4.5 (1.5) 4.2 (1.6) 
Range of Motion (°) (SD)     
Thumb     
IP extension†  10 (11) 11 (16) 11 (9) 10 (14) 
IP flexion 64 (12) 62 (12) 61 (15) 61 (11) 
MCP extension† 15 (15) 11 (18) 13 (10) 16 (14) 
MCP flexion 41 (13) 41 (14) 39 (15) 40 (10) 
Palmar abduction 39 (10) 40 (10) 36 (8) 37 (9) 
Radial abduction 42 (7) 42 (7) 45 (7) 44 (7) 
Opposition (mm)‡ 7 (0, 11) 8 (0, 13) 6 (0, 10) 6 (0, 11) 
Wrist (°) (SD)     
Flexion 60 (14) 57 (14) 65 (14) 63 (12) 
Extension 60 (13) 56 (11) 62 (13) 63 (12) 
Radial deviation 23 (13) 20 (7) 20 (7) 20 (5) 
Ulnar deviation 39 (10) 40 (10) 39 (9) 42 (9) 
Values are mean (SD) unless otherwise specified. 
*16 patients had undergone contralateral APL arthroplasty (6 before and 10 after the study period) and 2 patients had 
undergone contralateral CMC1 fusion before the study period. 
†Values represent hyperextension; MCP fusion in 2 operated and 2 contralateral hands in the unilateral group and in 3 
hands (2 right and 1 left) in the bilateral group, and MCP extension deficit (>10º) was present in 1 operated hand and 2 
contralateral hands in the unilateral group.  
‡Values are median (quartiles) distance to base of small finger. 
IP - interphalangeal; MCP - metacarpophalangeal 
Radiographic evaluation 
The mean unloaded trapezial space was 4.6 mm (SD 2.3, median 4.4, range 0.6-12.7 
mm). The median Kellgren-Lawrence OA grade was 2 for the ST joint, with OA grade 
of 2 to 4 seen in 72 (72%) of joints. Among the 39 unilaterally operated patients with 
unoperated contralateral CMC1 joint, ST OA grade 2 to 4 was observed in 26 (67%) of 
the operated hands and 34 (87%) of the contralateral hands (Table 12). 
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Table 12. Radiographic Scaphotrapezoid Joint Osteoarthritis (ST OA) 
OA grade* All operated  hands 
n=101† 
Operated hands with unoperated contralateral CMC1 
joint (n=39) 
Operated Operated Contralateral 
0 10 (10) 4 (10) 4 (10) 
1 18 (18) 9 (23) 1 (3) 
2 30 (30) 12 (31) 13 (33) 
3 30 (30) 8 (21) 11 (28) 
4 12 (12) 6 (15) 10 (26) 
Values are n (%) 
*Kellgren-Lawrence grading, range 0 (no OA) to 4 (most severe OA). 
†1 hand had been revised with fusion of the scaphotrapezoid joint before follow-up. 
The estimated association between trapezial space and pinch strength (in kg per 1-mm 
increase in trapezial space) was 0.05 (95% CI -0.07 to 0.16) when adjusted for age, sex 
and side and 0.07 (95% CI -0.04 to 0.18) when additionally adjusted for pain and STT 
OA grade. The model adjusting for time since surgery gave similar results (0.05, 95% 
CI -0.07 to 0.17). 
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Discussion 
Epidemiology of CMC1 OA 
The majority of studies on the epidemiology of CMC1 OA are based on radiographic 
reviews or questionnaire/census studies.36,127,142,143 A recent report from the 
Framingham Osteoarthritis Study used evaluations of radiographs in combination with 
interviews where subjects self-reported pain, aching, or stiffness in joints of the hand.142 
Reporting perceived pain, with or without correlative radiographs, is not equivalent to 
a physician diagnosis of OA. We identified subjects who were assigned a diagnosis 
specific to CMC1 OA by a physician; 63% of subjects were assigned a diagnosis by a 
specialist in orthopedics or hand surgery. Thus, the epidemiological estimates presented 
in this study are based on more stringent criteria, rather than on X-rays only or patient 
perception of OA. 
Our findings confirm the previously noted sex differences in the prevalence of CMC1 
OA, with women receiving a diagnosis nearly 4 times more than men.  This difference 
has been previously reported in both radiologic35 and interview127 studies.  In a study of 
men and women with early CMC1 OA as well as asymptomatic controls, investigators 
noted increased joint space narrowing in women with early OA as well as older 
asymptomatic women, a pattern not seen in men.38 
Evaluation by age showed a peak prevalence in women between 70-74 years, with the 
peak in men a decade older at 80-84 years, when evaluating the entire population over 
time. These findings mirror other epidemiological studies, showing highest incidence 
over 75 years.36,144 We evaluated prevalence in 5 year increments up to 80 years, with 
resulting high specificity in peaks of presentation. 
We evaluated an incidence proportion for CMC1 OA for the year 2012, noting that the 
peak rate of first time CMC1 OA diagnosis in women was a decade earlier at 60-69 
years, with men also showing the highest consultation rate a decade earlier at 70-79 
years. These findings suggest that this site of hand OA is a primary complaint and reason 
for seeking care at these ages. A recent study of conservative management of CMC1 
OA showed similar baseline age of 60 years in a group of 391 patients treated with 
orthosis and therapy.145 The drop in diagnoses in the oldest population groups may 
indicate that medical care is more focused on cardiac or other common health issues at 
advanced ages. 
Our study was limited primarily by database limitations; specifically, the SHR does not 
include radiographic data, precluding any correlation of OA diagnosis with X-rays. 
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Additionally, the side of OA or length of symptoms is not available for analysis but 
would be very useful in forming a more comprehensive picture of this disease’s 
prevalence. 
Occupation and Risk of CMC1 OA 
The link between occupational load and the development of CMC1 OA has been 
explored primarily in small case series. Fontana et al evaluated a group of women 
treated with surgery for CMC1 OA, with age-matched control group without history of 
CMC1 OA.48 The authors then performed a detailed qualitative interview to evaluate 
occupational factors, and noted that the primary risk factors for CMC1 OA were 
occupations presumed ‘at risk’ for CMC1 OA (secretaries, dressmakers, tailors, 
domestic helpers and cleaners); repetitive thumb use, and jobs perceived by the subjects 
as not having enough rest breaks in the day. A recent meta-analysis of 19 studies focused 
on finger and wrist OA showed an association between pinch grip work and CMC1 
OA.146 
We performed a comprehensive analysis of occupation, with stratification of load stress, 
and showed a dose-response linear relationship between increased occupational load 
and odds ratio of diagnosis of CMC1 OA in men.  In women, the highest odds ratio of 
CMC1 OA was related to the light-moderate group.  Overall, the highest risk of CMC1 
OA was in the heavy occupational group, confirming findings in the biomechanical 
literature which have shown that mechanical loading is associated with development 
and progression of OA.147 
The findings of similar risks of CMC1 OA between repetitive and heavy occupation in 
women within the subset of persons performing fine manipulation or repetitive hand 
grasp or grip are consistent with previous studies in CMC1 OA.48 This suggests a role 
for repetitive use as an additional mechanism for the development of CMC1 OA, 
especially in women. Recent findings of weaker key pinch strength in subjects with 
early CMC1 OA suggest that early awareness of occupational risk could be useful for 
employers and workers.148 
This study was limited by SHR study limitations as detailed under paper I; in addition, 
other risk factors for CMC1 OA including family history, trauma, and obesity were not 
available in the register and thus not controlled for in the study.  Additionally, the 
categorization of occupational groups was based on previous definitions134 but is still 
subject to misclassification. 
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Comparing Sick Leave Length and Surgery Type in CMC1 
OA 
There are multiple surgical options for CMC1 OA, including trapeziectomy, suspension 
tendon arthroplasty, arthrodesis and implant arthroplasty.86,105,149,150   While soft tissue 
or tendon arthroplasty is the most commonly performed surgery,86 prosthetic implant 
arthroplasty is still an accepted surgical option in Scandinavia and elsewhere.81,105,106,140 
However, the issue of the cost of the implant has not been studied in depth but must be 
considered.151 The cost of an implant made of surgical-grade silicone or machined metal 
or plastic is charged in addition to surgical and hospital costs. A recent systematic 
review of implant arthroplasty for the CMC1 joint reported variable outcomes and 
failure rates among several prostheses, noting the extra cost of the implant itself.151  
When comparing sick leave length between patients treated with implant and soft tissue 
arthroplasty in the Skåne population, our study demonstrated that implant arthroplasty 
was associated with shorter sick leave than soft tissue arthroplasty, by a mean of 30 
days, especially in patients without other comorbidities. These findings are similar to 
those in a prospective study of CMC1 implant surgery compared to tendon 
interposition.152 The authors compared 84 patients with an Ivory prosthesis with 
significantly better outcomes measures and faster return to work, at 4.7 months, to a 
group of 62 patients treated with LRTI who returned at a mean of 8.9 months. 
It has been postulated that implant arthroplasty allows faster return of function and more 
rapid ability to resume activities and occupation because of the immediate stability 
afforded by placement of an implant, as opposed to the need to wait for healing of soft 
tissues to stabilize the joint.153 A series of 100 patients treated with Elektra prostheses 
demonstrated outcomes with return to function at 7 weeks post surgery (occupational 
return was not specified), and mean grip of 28 (range, 15-50 kg) at 5 months post 
surgery.154   
In our study, men and women had comparable lengths of sick leave for both surgical 
procedures. Additionally, age did not impact sick leave length, similar to Katz’s findings 
about time off after carpal tunnel release.155 The length of sick leave overall was 
substantial, and must be considered within the context of a health system with support 
for time away from work.156 A comparison of sick leave policies across the 22 countries 
ranked at the top of the United Nations Human Development Index indicated that 
countries with substantial support for time out of work for illness, surgery, or family 
illness include Sweden, Denmark, and the United Kingdom.157 In contrast, the United 
States, Canada, and Japan have no national policies to support workers recovering from 
flu illness and limited medical leave policies overall. 
Our study was limited by database information limitations from the SHR register, which 
prevents knowledge of the exact prosthetic implant used in surgery or the surgical soft 
tissue technique, as these could influence results. In addition, there are limitations in the 
Social Insurance register, which does not specifically identify the cause of sick leave. 
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While it is likely safe to assume that sick leave in close proximity to a surgical procedure 
is due to that procedure, we cannot confirm this definitively.   
Long-Term Outcomes of Trapeziectomy and APL 
Suspension-Interposition Arthroplasty 
Our cohort study of a tightly captured surgical cohort presents the longest followup 
available for soft tissue arthroplasty at mean of 17 years. Trapeziectomy and ligament 
reconstruction using tendon is the most commonly performed surgery for CMC1 
OA,158,159 but long term followup is lacking. Avisar et al presented a series of 13 patients 
(15 thumbs) with a mean of 15 years of followup, noting minimal pain and grip/pinch 
comparable to the unoperated side.94 Another study compared trapeziectomy to 
ligament reconstruction and arthrodesis, with longest followup at 13 years, and noted 
similar outcomes with regard to pain, function, and satisfaction.160 
The strengths of this study include in-person followup on 81% of the original cohort, 
with comprehensive examination, outcomes measures, and radiographs. This stringent 
followup allows an in depth evaluation of the results of APL suspensionplasty surgery 
with honest assessment over time. The results suggest that for most patients this 
procedure yields durable results with overall good long-term pain relief and function as 
evaluated with the thumb-specific pain scale and QuickDASH.  
Comparison with a cohort from the Swedish national quality registry for hand surgery 
(HAKIR) showed that the long-term follow-up QuickDASH scores in the study cohort 
(mean 26 in women and 17 in men) did not differ substantially from the 1-year 
postoperative scores in the HAKIR cohort (mean 29 in women and 12 in men).  
The results of the present study show some residual pain and activity limitations. 
Patients with CMC1 OA may have OA in other hand joints, which may cause some of 
the residual symptoms. This may explain the somewhat higher scores in the hand pain 
VAS than the thumb pain scale. Other comorbidities in this mainly elderly cohort may 
also contribute to higher QuickDASH scores.  
The limitations of this study include a single-center cohort, lack of preoperative 
measures of pain and function, and loss of a small percentage to followup. We attempted 
to address the lack of preoperative data with comparison to a contemporary cohort from 
the Swedish national quality registry. 
----------------------------------------------------------------------------------------------------- 
In summary, the findings of these research studies and the literature on this topic 
underline the significance of the CMC1 joint in daily function and the effect of CMC1 
OA on patients. While radiographic CMC1 OA does not always translate to 
symptomatic OA,42,161 those patients presenting for care do so because of impacted 
ability to perform both fine tasks and more manual functions.162,163 This type of hand 
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OA can affect occupation, particularly with activities that require repetitive loading of 
the thumb or hand.164 
In treating CMC1 OA, there is moderate evidence in support of splinting, corticosteroid 
injections, and therapy to reduce pain.59,165,166 When these modalities no longer help the 
patient, there are a multitude of surgical options as described in the introduction. While 
none have been shown to be superior, systematic reviews have shown simple 
trapeziectomy to have the lowest rate of complications.159,167,168   
In evaluation of outcomes after surgery, most studies present good to excellent 
results.86,169,170 The need for revision has been reported at 3-5%, secondary to retained 
osteophytes, nerve injury, painful subsidence, or persistent unexplained pain.111,117 
Salem and Davis noted degenerative changes at the joints adjacent to the trapezium at a 
mean of 6 years after surgery, to a greater degree in the simple trapeziectomy patients 
than the LRTI patients, but these radiographic changes did not impact functional 
outcomes, with no differences between groups.95 
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Conclusions 
This thesis has focused on several aspects of CMC1 OA: prevalence, occupation, and 
surgical outcomes. What have we learned from this research?   
• In individuals presenting for care of and diagnosed with CMC1 OA in Skåne, 
there is strong female predominance in a group made up primarily of those aged 
60 years and older. These findings represent clinically relevant evidence of the 
epidemiology of CMC1 OA, as they are drawn from a geographically contained 
population’s health care record, and indicate that the elderly population is 
impacted by this disease disproportionately. 
• Our findings suggest a link between occupational load and subsequent risk of 
CMC1 OA in a large population. In Skåne, we noted a monotonic relationship 
between increasing load at work and CMC1 OA diagnosis in men, and the 
highest odds of CMC1 OA diagnosis overall in the heaviest work group.   
• In a subgroup of working persons, those characterized as performing repetitive 
occupations also showed increased odds of CMC1 OA compared to the referent 
population. These findings may be used to counsel employers and patients 
about future risks depending on the job type. 
• In evaluation of comparative data on sick leave after either soft tissue CMC1 
surgery or implant arthroplasty, we noted that implant arthroplasty was 
associated with earlier return to work, by approximately 30 days. These 
differences were significant in patients presumed to have minimal comorbid 
disease, while those with other reasons for sick leave did not demonstrate a 
large difference in time out of work after implant or soft tissue CMC1 surgery.  
The results of this study would be most useful to surgeons in discussing these 
surgical options with patients. 
• In a rigorous analysis of long-term outcomes after trapeziectomy and APL 
suspension-interposition surgery in a group of 100 patients, 17-year follow-up 
in 96% showed physical function comparable to the unoperated side and 
patient-rated outcomes demonstrating good pain relief and subjectively 
improved function. The findings of this study confirm the durable results of this 
surgery for CMC1 OA and can be used to counsel patients about expected 
results. 
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Future Perspectives 
While many of the aspects of CMC1 OA have been well-studied, there remain several 
unanswered questions. The lack of direct association between radiographic changes and 
symptomatic CMC1 joint symptoms is not well-explained.  One possible explanation is 
the genetic basis of this disease, which has been explored in a few studies. In Iceland, a 
large genetic database study of individuals with severe CMC1 OA and finger joint OA 
demonstrated associated risk alleles for a gene, ALDH1A2, which encodes aldehyde 
dehydrogenase.171 This gene is highly expressed in cartilage. Other studies showed an 
association of polymorphism in the MATN3 gene with CMC1 OA.172 This gene encodes 
matrilin-3, a protein component of the extracellular matrix of joints. 
Another important topic to address in future studies would be the need for secondary 
surgery after soft tissue arthroplasty, as this is the most commonly performed procedure 
for CMC1 OA and the only studies performed on this topic are single-center 
retrospective reports. Finally, prevention and/or protection for early stage CMC1 OA 
are critical gaps in knowledge; we as surgeons and scientists know how to treat the 
disease once established, but do not have effective tools to prevent it or slow its course. 
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